{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:17:58Z","timestamp":1767172678182,"version":"build-2238731810"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guangxi Higher Education Undergraduate Teaching Reform Project","award":["2022JGA146"],"award-info":[{"award-number":["2022JGA146"]}]},{"name":"Guangxi Educational Science Planning Key Project","award":["2022ZJY2791"],"award-info":[{"award-number":["2022ZJY2791"]}]},{"name":"Guangxi Medical University Undergraduate Education and Teaching Reform Project","award":["2023Z10"],"award-info":[{"award-number":["2023Z10"]}]},{"name":"Guangxi Zhuang Autonomous Region Health Commission Scientific Research Project","award":["Z-A20230519"],"award-info":[{"award-number":["Z-A20230519"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to explore the expression, molecular mechanism and its biological function of potassium two pore domain channel subfamily K member 1 (KCNK1) in bladder cancer (BC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We integrated large numbers of external samples (n\u2009=\u20091486) to assess KCNK1 mRNA expression levels and collected in-house samples (n\u2009=\u2009245) for immunohistochemistry (IHC) experiments to validate at the KCNK1 protein level. Single-cell RNA sequencing (scRNA-seq) analysis was performed to further assess KCNK1 expression and cellular communication. The transcriptional regulatory mechanisms of KCNK1 expression were explored by ChIP-seq, ATAC-seq and ChIA-PET data. Highly expressed co-expressed genes (HECEGs) of KCNK1 were used to explore potential signalling pathways. Furthermore, the immunoassay, clinical significance and molecular docking of KCNK1 were calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>KCNK1 mRNA was significantly overexpressed in BC (SMD\u2009=\u20090.58, 95% CI [0.05; 1.11]), validated at the protein level (p\u2009&lt;\u20090.0001). Upregulated KCNK1 mRNA exhibited highly distinguishing ability between BC and control samples (AUC\u2009=\u20090.82 [0.78\u20130.85]). Further, scRNA-seq analysis revealed that KCNK1 expression was predominantly clustered in BC epithelial cells and tended to increase with cellular differentiation. BC epithelial cells were involved in cellular communication mainly through the MK signalling pathway. Secondly, the KCNK1 transcription start site (TSS) showed promoter-enhancer interactions in three-dimensional space, while being transcriptionally regulated by GRHL2 and FOXA1. Most of the KCNK1 HECEGs were enriched in cell cycle\u2013related signalling pathways. KCNK1 was mainly involved in cellular metabolism\u2013related pathways and regulated cell membrane potassium channel activity. KCNK1 expression was associated with the level of infiltration of various immune cells. Immunotherapy and chemotherapy (docetaxel, paclitaxel and vinblastine) were more effective in BC patients in the high KCNK1 expression group. KCNK1 expression correlated with age, pathology grade and pathologic_M in BC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>KCNK1 was significantly overexpressed in BC. A complex and sophisticated three-dimensional spatial transcriptional regulatory network existed in the KCNK1 TSS and promoted the upregulated of KCNK1 expression. The high expression of KCNK1 might be involved in the cell cycle, cellular metabolism, and tumour microenvironment through the regulation of potassium channels, and ultimately contributed to the deterioration of BC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40001-024-01844-1","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T03:02:24Z","timestamp":1714446144000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Overexpressed KCNK1 regulates potassium channels affecting molecular mechanisms and biological pathways in bladder cancer"],"prefix":"10.1186","volume":"29","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Song","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bang-Teng","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Qing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Quan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Guang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"1844_CR1","doi-asserted-by":"publisher","first-page":"1297542","DOI":"10.3389\/fimmu.2024.1297542","volume":"15","author":"Y Huang","year":"2024","unstructured":"Huang Y, et al. A bibliometric insight into neoadjuvant chemotherapy in bladder cancer: trends, collaborations, and future avenues. Front Immunol. 2024;15:1297542.","journal-title":"Front Immunol"},{"issue":"3","key":"1844_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3390\/jpm13030512","volume":"13","author":"B Barone","year":"2023","unstructured":"Barone B, et al. Bladder cancer and risk factors: data from a multi-institutional long-term analysis on cardiovascular disease and cancer incidence. J Pers Med. 2023;13(3):512.","journal-title":"J Pers Med"},{"issue":"5","key":"1844_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin. 2020;70(5):404\u201323.","journal-title":"CA Cancer J Clin"},{"issue":"13","key":"1844_CR4","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.3390\/diagnostics13132308","volume":"13","author":"M Ferro","year":"2023","unstructured":"Ferro M, et al. Artificial intelligence in the advanced diagnosis of bladder cancer-comprehensive literature review and future advancement. Diagnostics. 2023;13(13):2308.","journal-title":"Diagnostics"},{"issue":"1","key":"1844_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1844_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"J Alfred Witjes","year":"2024","unstructured":"Alfred Witjes J, et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines. Eur Urol. 2024;85(1):17\u201331.","journal-title":"Eur Urol"},{"issue":"11","key":"1844_CR7","doi-asserted-by":"publisher","first-page":"12106","DOI":"10.1002\/cam4.5900","volume":"12","author":"S Han","year":"2023","unstructured":"Han S, et al. Neoadjuvant therapy with camrelizumab plus gemcitabine and cisplatin for patients with muscle-invasive bladder cancer: a multi-center, single-arm, phase 2 study. Cancer Med. 2023;12(11):12106\u201317.","journal-title":"Cancer Med"},{"key":"1844_CR8","doi-asserted-by":"publisher","first-page":"110723","DOI":"10.1016\/j.intimp.2023.110723","volume":"123","author":"B de Ribeiro Souza","year":"2023","unstructured":"de Ribeiro Souza B, et al. A novel therapeutic strategy for non-muscle invasive bladder cancer: OncoTherad(R) immunotherapy associated with platelet-rich plasma. Int Immunopharmacol. 2023;123:110723.","journal-title":"Int Immunopharmacol"},{"issue":"697","key":"1844_CR9","doi-asserted-by":"publisher","first-page":"eabn4118","DOI":"10.1126\/scitranslmed.abn4118","volume":"15","author":"FC de Jong","year":"2023","unstructured":"de Jong FC, et al. Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guerin. Sci Transl Med. 2023;15(697):eabn4118.","journal-title":"Sci Transl Med"},{"key":"1844_CR10","doi-asserted-by":"publisher","first-page":"102530","DOI":"10.1016\/j.ctrv.2023.102530","volume":"115","author":"CM Ascione","year":"2023","unstructured":"Ascione CM, et al. Role of FGFR3 in bladder cancer: treatment landscape and future challenges. Cancer Treat Rev. 2023;115:102530.","journal-title":"Cancer Treat Rev"},{"key":"1844_CR11","doi-asserted-by":"publisher","first-page":"879391","DOI":"10.3389\/fonc.2022.879391","volume":"12","author":"K Lou","year":"2022","unstructured":"Lou K, et al. Prevention and treatment of side effects of immunotherapy for bladder cancer. Front Oncol. 2022;12:879391.","journal-title":"Front Oncol"},{"issue":"1","key":"1844_CR12","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1038\/s41467-022-30853-z","volume":"13","author":"TS Turney","year":"2022","unstructured":"Turney TS, Li V, Brohawn SG. Structural Basis for pH-gating of the K(+) channel TWIK1 at the selectivity filter. Nat Commun. 2022;13(1):3232.","journal-title":"Nat Commun"},{"issue":"3","key":"1844_CR13","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.18632\/aging.102751","volume":"12","author":"S Cheng","year":"2020","unstructured":"Cheng S, et al. Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes involved in the regrowth of clinically non-functioning pituitary adenoma. Aging. 2020;12(3):2408\u201327.","journal-title":"Aging"},{"issue":"3","key":"1844_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1177\/2472555220976126","volume":"26","author":"D McCoull","year":"2021","unstructured":"McCoull D, et al. A \u201ctarget class\u201d screen to identify activators of two-pore domain potassium (K2P) channels. SLAS Discov. 2021;26(3):428\u201338.","journal-title":"SLAS Discov"},{"issue":"5","key":"1844_CR15","doi-asserted-by":"publisher","first-page":"F793","DOI":"10.1152\/ajprenal.2000.279.5.F793","volume":"279","author":"F Lesage","year":"2000","unstructured":"Lesage F, Lazdunski M. Molecular and functional properties of two-pore-domain potassium channels. Am J Physiol Renal Physiol. 2000;279(5):F793-801.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"17","key":"1844_CR16","doi-asserted-by":"publisher","first-page":"5162","DOI":"10.7150\/jca.45604","volume":"11","author":"X Lin","year":"2020","unstructured":"Lin X, et al. The correlation and role analysis of KCNK2\/4\/5\/15 in human papillary thyroid carcinoma microenvironment. J Cancer. 2020;11(17):5162\u201376.","journal-title":"J Cancer"},{"key":"1844_CR17","doi-asserted-by":"publisher","first-page":"887887","DOI":"10.3389\/fmolb.2022.887887","volume":"9","author":"X Huang","year":"2022","unstructured":"Huang X, et al. The molecular, immune features, and risk score construction of intraductal papillary mucinous neoplasm patients. Front Mol Biosci. 2022;9:887887.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"1844_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11033-023-08942-z","volume":"51","author":"A Karatug Kacar","year":"2024","unstructured":"Karatug Kacar A, et al. Characterization and comparison of insulinoma tumor model and pancreatic damage caused by the tumor, and identification of possible markers. Mol Biol Rep. 2024;51(1):109.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"1844_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/s12935-021-02117-1","volume":"21","author":"F Xiong","year":"2021","unstructured":"Xiong F, Wu GH, Wang B, Chen YJ. Plastin-3 is a diagnostic and prognostic marker for pancreatic adenocarcinoma and distinguishes from diffuse large B-cell lymphoma. Cancer Cell Int. 2021;21(1):411.","journal-title":"Cancer Cell Int"},{"key":"1844_CR20","doi-asserted-by":"publisher","first-page":"154286","DOI":"10.1016\/j.prp.2022.154286","volume":"241","author":"X Sun","year":"2023","unstructured":"Sun X, et al. Identification of KCNK1 as a potential prognostic biomarker and therapeutic target of breast cancer. Pathol Res Pract. 2023;241:154286.","journal-title":"Pathol Res Pract"},{"issue":"7","key":"1844_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7): e47.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"1844_CR22","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1371\/journal.pgen.0030161","volume":"3","author":"JT Leek","year":"2007","unstructured":"Leek JT, Storey JD. Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet. 2007;3(9):1724\u201335.","journal-title":"PLoS Genet"},{"issue":"2","key":"1844_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20(2):163\u201372.","journal-title":"Nat Immunol"},{"issue":"6476","key":"1844_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.aax0249","volume":"367","author":"GS Gulati","year":"2020","unstructured":"Gulati GS, et al. Single-cell transcriptional diversity is a hallmark of developmental potential. Science. 2020;367(6476):405\u201311.","journal-title":"Science"},{"issue":"1","key":"1844_CR25","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, et al. Inference and analysis of cell-cell communication using cell chat. Nat Commun. 2021;12(1):1088.","journal-title":"Nat Commun"},{"issue":"D1","key":"1844_CR26","doi-asserted-by":"publisher","first-page":"D57","DOI":"10.1093\/nar\/gkac893","volume":"51","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, et al. ChromLoops: a comprehensive database for specific protein-mediated chromatin loops in diverse organisms. Nucleic Acids Res. 2023;51(D1):D57\u201369.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"1844_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1039\/C5MB00663E","volume":"12","author":"G Yu","year":"2016","unstructured":"Yu G, He QY. ReactomePA: an R\/Bioconductor package for reactome pathway analysis and visualization. Mol Biosyst. 2016;12(2):477\u20139.","journal-title":"Mol Biosyst"},{"issue":"3","key":"1844_CR28","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2(3):100141.","journal-title":"Innovation"},{"key":"1844_CR29","doi-asserted-by":"publisher","first-page":"687975","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng D, et al. IOBR: multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures. Front Immunol. 2021;12:687975.","journal-title":"Front Immunol"},{"key":"1844_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab260","author":"D Maeser","year":"2021","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021. https:\/\/doi.org\/10.1093\/bib\/bbab260.","journal-title":"Brief Bioinform"},{"issue":"11","key":"1844_CR31","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41556-022-01002-x","volume":"24","author":"KC Kao","year":"2022","unstructured":"Kao KC, Vilbois S, Tsai CH, Ho PC. Metabolic communication in the tumour-immune microenvironment. Nat Cell Biol. 2022;24(11):1574\u201383.","journal-title":"Nat Cell Biol"},{"key":"1844_CR32","doi-asserted-by":"publisher","first-page":"802463","DOI":"10.3389\/fendo.2021.802463","volume":"12","author":"W Wang","year":"2021","unstructured":"Wang W, Bo H, Liang Y, Li G. LINC00467 is upregulated by DNA copy number amplification and hypomethylation and shows ceRNA potential in lung adenocarcinoma. Front Endocrinol. 2021;12:802463.","journal-title":"Front Endocrinol"},{"issue":"8","key":"1844_CR33","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.cell.2023.01.038","volume":"186","author":"LWS Finley","year":"2023","unstructured":"Finley LWS. What is cancer metabolism? Cell. 2023;186(8):1670\u201388.","journal-title":"Cell"},{"issue":"11","key":"1844_CR34","doi-asserted-by":"publisher","first-page":"10875","DOI":"10.1007\/s11033-022-07788-1","volume":"49","author":"E Jamasbi","year":"2022","unstructured":"Jamasbi E, Hamelian M, Hossain MA, Varmira K. The cell cycle, cancer development and therapy. Mol Biol Rep. 2022;49(11):10875\u201383.","journal-title":"Mol Biol Rep"},{"key":"1844_CR35","doi-asserted-by":"publisher","first-page":"839986","DOI":"10.3389\/fcell.2022.839986","volume":"10","author":"Y Zou","year":"2022","unstructured":"Zou Y, et al. Integrative analysis of KCNK genes and establishment of a specific prognostic signature for breast cancer. Front Cell Dev Biol. 2022;10:839986.","journal-title":"Front Cell Dev Biol"},{"key":"1844_CR36","doi-asserted-by":"publisher","first-page":"1343804","DOI":"10.3389\/fcvm.2024.1343804","volume":"11","author":"N Shima","year":"2024","unstructured":"Shima N, et al. Up-regulated expression of two-pore domain K(+) channels, KCNK1 and KCNK2, is involved in the proliferation and migration of pulmonary arterial smooth muscle cells in pulmonary arterial hypertension. Front Cardiovasc Med. 2024;11:1343804.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"1844_CR37","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1523\/JNEUROSCI.1675-19.2019","volume":"40","author":"M Nagashima","year":"2020","unstructured":"Nagashima M, et al. Midkine-a is required for cell cycle progression of muller glia during neuronal regeneration in the vertebrate retina. J Neurosci. 2020;40(6):1232\u201347.","journal-title":"J Neurosci"},{"issue":"6","key":"1844_CR38","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.tibs.2018.12.007","volume":"44","author":"P Icard","year":"2019","unstructured":"Icard P, et al. Interconnection between metabolism and cell cycle in cancer. Trends Biochem Sci. 2019;44(6):490\u2013501.","journal-title":"Trends Biochem Sci"},{"issue":"4","key":"1844_CR39","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1007\/s11033-022-07116-7","volume":"49","author":"L Zhang","year":"2022","unstructured":"Zhang L, et al. Midkine promotes breast cancer cell proliferation and migration by upregulating NR3C1 expression and activating the NF-kappaB pathway. Mol Biol Rep. 2022;49(4):2953\u201361.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"1844_CR40","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1186\/s12935-021-02212-3","volume":"21","author":"B Hu","year":"2021","unstructured":"Hu B, et al. Midkine promotes glioblastoma progression via PI3K-Akt signaling. Cancer Cell Int. 2021;21(1):509.","journal-title":"Cancer Cell Int"},{"key":"1844_CR41","doi-asserted-by":"publisher","first-page":"172941","DOI":"10.1016\/j.ejphar.2020.172941","volume":"872","author":"J Zhang","year":"2020","unstructured":"Zhang J, et al. MiR-326 targets MDK to regulate the progression of cardiac hypertrophy through blocking JAK\/STAT and MAPK signaling pathways. Eur J Pharmacol. 2020;872:172941.","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"1844_CR42","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/pros.24117","volume":"81","author":"A Liotti","year":"2021","unstructured":"Liotti A, et al. Periprostatic adipose tissue promotes prostate cancer resistance to docetaxel by paracrine IGF-1 upregulation of TUBB2B beta-tubulin isoform. Prostate. 2021;81(7):407\u201317.","journal-title":"Prostate"},{"key":"1844_CR43","doi-asserted-by":"publisher","first-page":"215581","DOI":"10.1016\/j.canlet.2022.215581","volume":"532","author":"C Miro","year":"2022","unstructured":"Miro C, et al. Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancer. Cancer Lett. 2022;532:215581.","journal-title":"Cancer Lett"},{"issue":"1","key":"1844_CR44","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1038\/s41467-021-23482-5","volume":"12","author":"H Atcha","year":"2021","unstructured":"Atcha H, et al. Mechanically activated ion channel Piezo1 modulates macrophage polarization and stiffness sensing. Nat Commun. 2021;12(1):3256.","journal-title":"Nat Commun"},{"key":"1844_CR45","doi-asserted-by":"publisher","first-page":"976482","DOI":"10.3389\/fimmu.2022.976482","volume":"13","author":"S Leng","year":"2022","unstructured":"Leng S, et al. Ion channel Piezo1 activation promotes aerobic glycolysis in macrophages. Front Immunol. 2022;13:976482.","journal-title":"Front Immunol"},{"issue":"11","key":"1844_CR46","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/j.cmet.2022.08.016","volume":"34","author":"S Chen","year":"2022","unstructured":"Chen S, et al. Tumor-associated macrophages are shaped by intratumoral high potassium via Kir2.1. Cell Metab. 2022;34(11):1843-1859 e11.","journal-title":"Cell Metab"},{"issue":"15","key":"1844_CR47","doi-asserted-by":"publisher","first-page":"16279","DOI":"10.1002\/cam4.6236","volume":"12","author":"H Zhou","year":"2023","unstructured":"Zhou H, et al. KCND2: a prognostic biomarker and regulator of immune function in gastric cancer. Cancer Med. 2023;12(15):16279\u201394.","journal-title":"Cancer Med"},{"issue":"7621","key":"1844_CR48","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nature19364","volume":"537","author":"R Eil","year":"2016","unstructured":"Eil R, et al. Ionic immune suppression within the tumour microenvironment limits T cell effector function. Nature. 2016;537(7621):539\u201343.","journal-title":"Nature"},{"issue":"5","key":"1844_CR49","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3390\/cancers14051217","volume":"14","author":"JL Goggi","year":"2022","unstructured":"Goggi JL, et al. Imaging Kv1.3 expressing memory T cells as a marker of immunotherapy response. Cancers. 2022;14(5):1217.","journal-title":"Cancers"},{"issue":"3","key":"1844_CR50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1089\/bioe.2019.0016","volume":"1","author":"ST Ong","year":"2019","unstructured":"Ong ST, et al. Extracellular K(+) dampens T cell functions: implications for immune suppression in the tumor microenvironment. Bioelectricity. 2019;1(3):169\u201379.","journal-title":"Bioelectricity"},{"key":"1844_CR51","doi-asserted-by":"publisher","first-page":"114392","DOI":"10.1016\/j.biopha.2023.114392","volume":"160","author":"M Hashemi","year":"2023","unstructured":"Hashemi M, et al. Paclitaxel and docetaxel resistance in prostate cancer: molecular mechanisms and possible therapeutic strategies. Biomed Pharmacother. 2023;160:114392.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"1844_CR52","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2174\/1389450124666230731094837","volume":"24","author":"J Sebastian","year":"2023","unstructured":"Sebastian J, Rathinasamy K. Microtubules and cell division: potential pharmacological targets in cancer therapy. Curr Drug Targets. 2023;24(11):889\u2013918.","journal-title":"Curr Drug Targets"},{"issue":"24","key":"1844_CR53","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.3390\/cells11244067","volume":"11","author":"Z Wu","year":"2022","unstructured":"Wu Z, et al. Paclitaxel inhibits KCNQ channels in Primary sensory neurons to initiate the development of painful peripheral neuropathy. Cells. 2022;11(24):4067.","journal-title":"Cells"},{"issue":"2","key":"1844_CR54","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00232-014-9757-6","volume":"248","author":"T Sun","year":"2015","unstructured":"Sun T, et al. Docetaxel modulates the delayed rectifier potassium current (IK) and ATP-sensitive potassium current (IKATP) in human breast cancer cells. J Membr Biol. 2015;248(2):197\u2013204.","journal-title":"J Membr Biol"}],"updated-by":[{"DOI":"10.1186\/s40001-024-01905-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000}}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-01844-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-024-01844-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-01844-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T02:03:04Z","timestamp":1718848984000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-024-01844-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1844"],"URL":"https:\/\/doi.org\/10.1186\/s40001-024-01844-1","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,30]]},"assertion":[{"value":"26 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s40001-024-01905-5","URL":"https:\/\/doi.org\/10.1186\/s40001-024-01905-5","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Studies concerning human subjects have been approved and supported by the Medical Ethics Review Committee of the First Affiliated Hospital of Guangxi Medical University (2023-S058-01). All patients who provided internal samples signed an informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed the manuscript and agreed to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"257"}}